Literature DB >> 16766383

Dopaminergic regulation of glucose-induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro.

Eswar Shankar1, K T Santhosh, C S Paulose.   

Abstract

The stimulatory effect of dopamine through dopamine D2 receptor on glucose-induced insulin secretion was studied in the pancreatic islets in vitro. Dopamine significantly stimulated insulin secretion at a concentration of 10-8 M in the presence of high glucose (20 mM). The higher concentrations of dopamine (10(-7)-10(-4)) inhibited glucose-induced insulin secretion in the presence of both 4 mM and 20 mM glucose. Stimulatory and inhibitory effect of dopamine on glucose-induced insulin secretion was reverted by the addition of dopamine D2 receptor antagonists such as butaclamol and sulpiride. Norepinephrine (NE) at 10(-4) M concentration inhibited the dopamine uptake as well as its stimulatory effect at 10(-8) M concentration on glucose induced insulin secretion. Our results suggest that dopamine exerts a differential effect on glucose-induced insulin secretion through dopamine D2 receptor and it is essential for the regulation of glucose-induced insulin secretion by pancreatic islets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766383     DOI: 10.1080/15216540600687993

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  21 in total

1.  Severe Hypoglycemia Associated with Tiapride in an Elderly Patient with Diabetes and Psychosis.

Authors:  Takahiko Nagamine
Journal:  Innov Clin Neurosci       Date:  2017-02-01

2.  Neuroprotective effect of Cucumis melo Var. flexuosus leaf extract on the brains of rats with streptozotocin-induced diabetes.

Authors:  Doaa S Ibrahim
Journal:  Metab Brain Dis       Date:  2016-08-03       Impact factor: 3.584

3.  Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells.

Authors:  Antonella Maffei; Ann Marie Segal; Juan Carlos Alvarez-Perez; Adolfo Garcia-Ocaña; Paul E Harris
Journal:  Mol Endocrinol       Date:  2015-03-09

4.  ¹²⁴I-Epidepride: a PET radiotracer for extended imaging of dopamine D2/D3 receptors.

Authors:  Suresh Pandey; Archana Venugopal; Ritu Kant; Robert Coleman; Jogeshwar Mukherjee
Journal:  Nucl Med Biol       Date:  2014-01-31       Impact factor: 2.408

5.  Leucine acutely potentiates glucose-stimulated insulin secretion in fetal sheep.

Authors:  Brit H Boehmer; Peter R Baker; Laura D Brown; Stephanie R Wesolowski; Paul J Rozance
Journal:  J Endocrinol       Date:  2020-10       Impact factor: 4.286

6.  Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine.

Authors:  Anthony Raffo; Kolbe Hancock; Teresa Polito; Yuli Xie; Gordon Andan; Piotr Witkowski; Mark Hardy; Pasquale Barba; Caterina Ferrara; Antonella Maffei; Matthew Freeby; Robin Goland; Rudolph L Leibel; Ian R Sweet; Paul E Harris
Journal:  J Endocrinol       Date:  2008-07       Impact factor: 4.286

7.  Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro.

Authors:  Norman Simpson; Antonella Maffei; Matthew Freeby; Steven Burroughs; Zachary Freyberg; Jonathan Javitch; Rudolph L Leibel; Paul E Harris
Journal:  Mol Endocrinol       Date:  2012-08-21

Review 8.  VMAT2 gene expression and function as it applies to imaging beta-cell mass.

Authors:  Paul E Harris; Caterina Ferrara; Pasquale Barba; Teresa Polito; Matthew Freeby; Antonella Maffei
Journal:  J Mol Med (Berl)       Date:  2007-07-31       Impact factor: 4.599

Review 9.  Neurofunctional imaging of β-cell dynamics.

Authors:  P E Harris; R L Leibel
Journal:  Diabetes Obes Metab       Date:  2012-10       Impact factor: 6.577

10.  Imaging pancreas in healthy and diabetic rodent model using [18F]fallypride positron emission tomography/computed tomography.

Authors:  Adriana Garcia; Archana Venugopal; Min-Liang Pan; Jogeshwar Mukherjee
Journal:  Diabetes Technol Ther       Date:  2014-05-14       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.